News & Perspective

Oct 05, 2012

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Sep 15, 2014

Sep 15, 2014
Africa medical aid

UN security council to hold emergency Ebola talks

US lawmakers will hear from federal officials, ahead of an emergency UN Security Council meeting on Ebola.

Feb 03, 2015

Feb 03, 2015
Pills and money

Infectious-disease programs fare well in Obama's 2016 budget

Highlights include funds for antibiotic resistance, bioterrorism preparedness, and a unified food safety agency.

Jul 02, 2015

Jul 02, 2015
Vaccine vials

GSK upgrade delays supply of adjuvanted H5N1 vaccine

A recommendation for occupational use was tabled until the vaccine becomes available.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M logo Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»